These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7037955)
1. Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients. Merrill JE; Wåhlin B; Sidén A; Perlmann P J Immunol; 1982 Apr; 128(4):1728-35. PubMed ID: 7037955 [No Abstract] [Full Text] [Related]
2. Differential effect of interferon expression of IgG- and IgM-Fc receptors on human lymphocytes. Itoh K; Inoue M; Kataoka S; Kumagai K J Immunol; 1980 Jun; 124(6):2589-95. PubMed ID: 6154733 [No Abstract] [Full Text] [Related]
3. A T lymphocyte subpopulation in multiple sclerosis patients bearing Fc receptors for both IgG and IgM1. Merrill JE; Biberfeld G; Kolmodin G; Landin S; Norrby E J Immunol; 1980 Jun; 124(6):2758-64. PubMed ID: 6966297 [TBL] [Abstract][Full Text] [Related]
12. Regulation of IgG antibody-dependent cellular cytotoxicity in vitro by IgM antibodies. Perlmann H; Perlmann P; Moretta L; Rönnholm M Scand J Immunol; 1981 Jul; 14(1):47-60. PubMed ID: 7313557 [TBL] [Abstract][Full Text] [Related]
13. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity. Saxena RK; Saxena QB; Adler WH Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998 [TBL] [Abstract][Full Text] [Related]
14. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480 [TBL] [Abstract][Full Text] [Related]
15. [The lymphocyte abnormality in CNS disease]. Matsubara H; Igata A No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216 [No Abstract] [Full Text] [Related]
16. [The effect of gamma-interferon and phorbol myristate acetate on the Fc gamma-receptor ligand-binding capacity and on the target-conjugating and antibody-dependent cytotoxic activity of blood lymphocytes]. Miliukiene VV; Dediniene JL Tsitologiia; 1997; 39(8):681-7. PubMed ID: 9490506 [TBL] [Abstract][Full Text] [Related]
17. Differences in the cytologic characteristics of antibody-dependent cellular cytotoxicity of normal and leukemic bovine blood lymphocytes. Adomaitiene D; Dediniene J Anal Quant Cytol; 1981 Jun; 3(2):143-8. PubMed ID: 7258857 [TBL] [Abstract][Full Text] [Related]
18. Defective mononuclear cell antibody-dependent cellular cytotoxicity (ADCC) in patients with leukocyte adhesion deficiency emphasizing on different CD11/CD18 requirement of Fc gamma RI versus Fc gamma RII in ADCC. Majima T; Ohashi Y; Nagatomi R; Iizuka A; Konno T Cell Immunol; 1993 May; 148(2):385-96. PubMed ID: 8098672 [TBL] [Abstract][Full Text] [Related]
19. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines. Komatsu F; Tamiya H Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513 [TBL] [Abstract][Full Text] [Related]
20. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. Ault KA; Springer TA J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]